Medical research

Scientists establish a new class of anti-diabetic compound

In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.

Medical research

Scientists develop a new type of anti-cancer agent

Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumor remission, partly due to the presence of cancer stem cells, which are difficult to eradicate. These cells can self-renew ...

Genetics

Study examines the possible role of KIF5A gene in ALS

A study by researchers at The Ohio State University Wexner Medical Center and College of Medicine used a newly developed mouse model to examine the possible role of a gene called KIF5A in the development of amyotrophic lateral ...

Psychology & Psychiatry

Using ketamine to find an undiscovered pathway in depression

For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and ...

Oncology & Cancer

Novel class of drugs may help treat deadly lymphoma

A new class of drugs that inhibits a 'master switch' involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Psychology & Psychiatry

Sex change hormonal treatments alter brain chemistry

Hormonal treatments administered as part of the procedures for sex reassignment have well-known and well-documented effects on the secondary sexual characteristics of the adult body, shifting a recipient's physical appearance ...

Oncology & Cancer

Professor fights cancer with hedgehogs

A Binghamton University biochemist has discovered a new way to fight cancer, one that attacks only the cancer cells and promises fewer side effects. He hunts hedgehogs.

page 3 from 5